Hui Li

机构：Nanjing University of Chinese Medicine, Shantou University, Shantou University Mental Health Center, Nanjing Drum Tower Hospital, Shantou University Medical College, Qilu Pharmaceutical Co., Ltd. (China) · ORCID：0000-0001-8117-6347

发表论文 63 篇 · 总被引 1659 次 · h-index 18

代表论文

• Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19 (2018 · Cell · 被引 325)
• Aberrant Prefrontal–Thalamic–Cerebellar Circuit in Schizophrenia and Depression: Evidence From a Possible Causal Connectivity (2018 · International Journal of Neural Systems · 被引 59)
• No causal effects of plasma homocysteine levels on the risk of coronary heart disease or acute myocardial infarction: A Mendelian randomization study (2019 · European Journal of Preventive Cardiology · 被引 53)
• Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial (2019 · Neuropsychiatric Disease and Treatment · 被引 45)
• Increased Neutrophil Activation and Plasma DNA Levels in Patients with Pre-Eclampsia (2018 · Thrombosis and Haemostasis · 被引 44)
• Interpretation of breast cancer screening guideline for Chinese women (2019 · Cancer Biology and Medicine · 被引 43)